X0609 4 2026-07-15 0001770069 MapLight Therapeutics, Inc. MPLT 0001728746 Lillie James Woodruff false C/O MAPLIGHT THERAPEUTICS, INC. 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 false true false false Chief Scientific Officer 0 Voting Common Stock 2026-07-15 4 S 0 2238 36 D 240491 D Voting Common Stock 2026-07-15 4 S 0 5393 36.99 D 235098 D Voting Common Stock 2026-07-15 4 S 0 12 37.54 D 235086 D Voting Common Stock 2026-07-16 4 S 0 5009 36.45 D 230077 D Voting Common Stock 2026-07-16 4 S 0 3526 37.26 D 226551 D Voting Common Stock 2026-07-16 4 S 0 12 37.96 D 226539 D Voting Common Stock 2026-07-17 4 S 0 2077 37.90 D 224462 D Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.5338 to $36.5251 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.53 to $37.405 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.9075 to $36.9013 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.9082 to $37.89 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.49 to $37.925 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. /s/ Kristopher L. Hanson, Attorney-in-Fact 2026-07-17